Novo Holdings A just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13D. In the filing, it appears as though Novo Holdings A claims to own 1,389,498 shares. This represents 4.97% of Corvus Pharmaceuticals, Inc..
Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.
To receive a free e-mail notification whenever Corvus Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
On September - Sept. 17, 2020
Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Sept. 15, 2020
Corvus Pharmaceuticals, Inc. director just declared 0 ownership of the company. - Sept. 15, 2020
Departure of Directors or Certain - Sept. 11, 2020
On September - Sept. 10, 2020